Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

Get in touch

1800 437 222

Viral hepatitis (A, B & C)

Hepatitis means inflammation of the liver, and it can be caused by a virus or other non-viral causes.  The main difference between the viruses is how they are spread and the effects they have on your health.

Read more...

Prevention

There are safe and effective vaccines that protect you from getting hepatitis A and B.  While there is no vaccine for hep C, by being ‘blood aware’ you can reduce your overall chance of being exposed to the virus.

Read more...

Living with Hepatitis

People with chronic hepatitis can do a number of things to stay healthy including limiting/avoiding alcohol, reducing stress, not smoking, getting regular exercise and eating a healthy diet.

Read more...

Treatment

Effective treatment is available for both chronic hepatitis B and C.  Before you can see a liver specialist to talk about going on treatment, you need to get a referral from your GP first.

Read more...
ContentViewArticle Object
(
    [item:protected] => stdClass Object
        (
            [id] => 314
            [asset_id] => 388
            [title] => Hepatitis C Inquiry Report welcomed; but urgent action now needed
            [alias] => hepatitis-c-inquiry-report-welcomed-but-urgent-action-now-needed
            [title_alias] => 
            [introtext] => 

Hepatitis Australia Media Release

For Immediate Use

26 June 2015


The report by the House of Representatives Standing Committee on Health, The Silent Disease - Inquiry into Hepatitis C in Australia has been welcomed by the peak body representing the interests of more than 230,000 Australians living with hepatitis C.

The Acting CEO of Hepatitis Australia Kevin Marriott thanked the House of Representatives Committee for their comprehensive report, which included input from more than one hundred submissions and five public hearings.

"The Inquiry has been a landmark moment for Australians living with hepatitis C. It allowed many people to make their voice heard and we thank the Committee for listening and acknowledging the diverse experiences of people impacted by hepatitis C," he said.

"The report includes a number of important recommendations, including improved data collection and monitoring of progress against the targets in the National Hepatitis C Strategy - which we strongly welcome."

"The introduction of robust targets to increase testing and supporting the use in Australia of new rapid testing technology is also a step in the right direction."

However, Hepatitis Australia believes the report falls short in two important areas - affordable access to new generation anti-viral medicines and the prevention of blood borne viruses in correctional settings.

"We are disappointed that the report is silent on recommendations around new treatment options for hepatitis C, which have been deemed cost-effective and are now awaiting a PBS listing date. These therapies offer the opportunity to transform lives and make hepatitis C a rare condition in our lifetime," Mr Marriott said.

"Hepatitis Australia remains steadfast in its position that there can be no further delay in access to interferon-free medicines for all people living with chronic hepatitis C."

Mr Marriott also welcomed the Committee's recommendation that a national strategy be developed to urgently address blood borne viruses in prisons and pointed to evidence that needle and syringe programs significantly reduce rates of hepatitis C transmission.

"Ensuring safe and hygienic tattooing and barbering practises in prisons is essential, as well as trialling a needle and syringe exchange program in at least one Australian prison, with the view to rolling out the strongest possible program nationally," he said.

"We look forward to the Government acting on the recommendations from the Committee and going one step further - making new hepatitis C medicines affordable as soon as possible, and working to remove barriers to the introduction of needle and syringe programs in prisons."

Media Contact: Fiona Beveridge 0405 902 826

If you are living with hepatitis C, please call the National Infoline on 1300 437 222

Click here for a PDF version of this media release.

Older news:

[fulltext] => [state] => 1 [mask] => 0 [catid] => 3 [created] => 2015-06-26 04:11:05 [created_by] => 66 [created_by_alias] => [modified] => 2015-06-26 04:18:58 [modified_by] => 66 [checked_out] => 66 [checked_out_time] => 2015-06-26 04:18:58 [publish_up] => 2015-06-26 04:11:05 [publish_down] => 0000-00-00 00:00:00 [images] => [urls] => [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [version] => 5 [parentid] => 0 [ordering] => 84 [metakey] => [metadesc] => [access] => 1 [hits] => 1908 [metadata] => JRegistry Object ( [data:protected] => stdClass Object ( [robots] => [author] => [rights] => [xreference] => ) ) [featured] => 0 [language] => * [xreference] => [category_title] => News & Events [category_alias] => news-a-events [category_access] => 1 [author] => Hepatitis Admin [contactid] => [parent_title] => General [parent_id] => 15 [parent_route] => general [parent_alias] => general [rating] => [rating_count] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [menu_text] => 1 [show_page_heading] => 0 [secure] => 0 [page_title] => Latest News [page_description] => Hepatitis Queensland [page_rights] => [robots] => [access-view] => 1 ) ) [slug] => 314:hepatitis-c-inquiry-report-welcomed-but-urgent-action-now-needed [catslug] => 3:news-a-events [parent_slug] => 15:general [readmore_link] => /news-media-a-events/our-news/3-news-a-events/314-hepatitis-c-inquiry-report-welcomed-but-urgent-action-now-needed [text] =>

Hepatitis Australia Media Release

For Immediate Use

26 June 2015


The report by the House of Representatives Standing Committee on Health, The Silent Disease - Inquiry into Hepatitis C in Australia has been welcomed by the peak body representing the interests of more than 230,000 Australians living with hepatitis C.

The Acting CEO of Hepatitis Australia Kevin Marriott thanked the House of Representatives Committee for their comprehensive report, which included input from more than one hundred submissions and five public hearings.

"The Inquiry has been a landmark moment for Australians living with hepatitis C. It allowed many people to make their voice heard and we thank the Committee for listening and acknowledging the diverse experiences of people impacted by hepatitis C," he said.

"The report includes a number of important recommendations, including improved data collection and monitoring of progress against the targets in the National Hepatitis C Strategy - which we strongly welcome."

"The introduction of robust targets to increase testing and supporting the use in Australia of new rapid testing technology is also a step in the right direction."

However, Hepatitis Australia believes the report falls short in two important areas - affordable access to new generation anti-viral medicines and the prevention of blood borne viruses in correctional settings.

"We are disappointed that the report is silent on recommendations around new treatment options for hepatitis C, which have been deemed cost-effective and are now awaiting a PBS listing date. These therapies offer the opportunity to transform lives and make hepatitis C a rare condition in our lifetime," Mr Marriott said.

"Hepatitis Australia remains steadfast in its position that there can be no further delay in access to interferon-free medicines for all people living with chronic hepatitis C."

Mr Marriott also welcomed the Committee's recommendation that a national strategy be developed to urgently address blood borne viruses in prisons and pointed to evidence that needle and syringe programs significantly reduce rates of hepatitis C transmission.

"Ensuring safe and hygienic tattooing and barbering practises in prisons is essential, as well as trialling a needle and syringe exchange program in at least one Australian prison, with the view to rolling out the strongest possible program nationally," he said.

"We look forward to the Government acting on the recommendations from the Committee and going one step further - making new hepatitis C medicines affordable as soon as possible, and working to remove barriers to the introduction of needle and syringe programs in prisons."

Media Contact: Fiona Beveridge 0405 902 826

If you are living with hepatitis C, please call the National Infoline on 1300 437 222

Click here for a PDF version of this media release.

Older news:

[event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) ) [params:protected] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [menu_text] => 1 [show_page_heading] => 0 [secure] => 0 [page_title] => Latest News [page_description] => Hepatitis Queensland [page_rights] => [robots] => [page_heading] => Latest News ) ) [print:protected] => [state:protected] => JObject Object ( [_errors:protected] => Array ( ) [task] => [parameters.menu] => JRegistry Object ( [data:protected] => stdClass Object ( [show_title] => [link_titles] => [show_intro] => [show_category] => [link_category] => [show_parent_category] => [link_parent_category] => [show_author] => [link_author] => [show_create_date] => [show_modify_date] => [show_publish_date] => [show_item_navigation] => [show_vote] => [show_icons] => [show_print_icon] => [show_email_icon] => [show_hits] => [show_noauth] => [urls_position] => [menu-anchor_title] => [menu-anchor_css] => [menu_image] => [menu_text] => 1 [page_title] => [show_page_heading] => 0 [page_heading] => [pageclass_sfx] => [menu-meta_description] => [menu-meta_keywords] => [robots] => [secure] => 0 ) ) [article.id] => 314 [list.offset] => 0 [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [menu_text] => 1 [show_page_heading] => 0 [secure] => 0 [page_title] => Latest News [page_description] => Hepatitis Queensland [page_rights] => [robots] => [page_heading] => Latest News ) ) [filter.published] => 1 [filter.archived] => 2 [filter.language] => ) [user:protected] => JUser Object ( [isRoot:protected] => [id] => 0 [name] => [username] => [email] => [password] => [password_clear] => [usertype] => [block] => [sendEmail] => 0 [registerDate] => [lastvisitDate] => [activation] => [params] => [groups] => Array ( ) [guest] => 1 [lastResetTime] => [resetCount] => [_params:protected] => JRegistry Object ( [data:protected] => stdClass Object ( ) ) [_authGroups:protected] => Array ( [0] => 1 ) [_authLevels:protected] => Array ( [0] => 1 [1] => 1 ) [_authActions:protected] => [_errorMsg:protected] => [_errors:protected] => Array ( ) [aid] => 0 ) [_name:protected] => article [_models:protected] => Array ( [article] => ContentModelArticle Object ( [_context:protected] => com_content.article [_item:protected] => Array ( [314] => stdClass Object ( [id] => 314 [asset_id] => 388 [title] => Hepatitis C Inquiry Report welcomed; but urgent action now needed [alias] => hepatitis-c-inquiry-report-welcomed-but-urgent-action-now-needed [title_alias] => [introtext] =>

Hepatitis Australia Media Release

For Immediate Use

26 June 2015


The report by the House of Representatives Standing Committee on Health, The Silent Disease - Inquiry into Hepatitis C in Australia has been welcomed by the peak body representing the interests of more than 230,000 Australians living with hepatitis C.

The Acting CEO of Hepatitis Australia Kevin Marriott thanked the House of Representatives Committee for their comprehensive report, which included input from more than one hundred submissions and five public hearings.

"The Inquiry has been a landmark moment for Australians living with hepatitis C. It allowed many people to make their voice heard and we thank the Committee for listening and acknowledging the diverse experiences of people impacted by hepatitis C," he said.

"The report includes a number of important recommendations, including improved data collection and monitoring of progress against the targets in the National Hepatitis C Strategy - which we strongly welcome."

"The introduction of robust targets to increase testing and supporting the use in Australia of new rapid testing technology is also a step in the right direction."

However, Hepatitis Australia believes the report falls short in two important areas - affordable access to new generation anti-viral medicines and the prevention of blood borne viruses in correctional settings.

"We are disappointed that the report is silent on recommendations around new treatment options for hepatitis C, which have been deemed cost-effective and are now awaiting a PBS listing date. These therapies offer the opportunity to transform lives and make hepatitis C a rare condition in our lifetime," Mr Marriott said.

"Hepatitis Australia remains steadfast in its position that there can be no further delay in access to interferon-free medicines for all people living with chronic hepatitis C."

Mr Marriott also welcomed the Committee's recommendation that a national strategy be developed to urgently address blood borne viruses in prisons and pointed to evidence that needle and syringe programs significantly reduce rates of hepatitis C transmission.

"Ensuring safe and hygienic tattooing and barbering practises in prisons is essential, as well as trialling a needle and syringe exchange program in at least one Australian prison, with the view to rolling out the strongest possible program nationally," he said.

"We look forward to the Government acting on the recommendations from the Committee and going one step further - making new hepatitis C medicines affordable as soon as possible, and working to remove barriers to the introduction of needle and syringe programs in prisons."

Media Contact: Fiona Beveridge 0405 902 826

If you are living with hepatitis C, please call the National Infoline on 1300 437 222

Click here for a PDF version of this media release.

Older news:

[fulltext] => [state] => 1 [mask] => 0 [catid] => 3 [created] => 2015-06-26 04:11:05 [created_by] => 66 [created_by_alias] => [modified] => 2015-06-26 04:18:58 [modified_by] => 66 [checked_out] => 66 [checked_out_time] => 2015-06-26 04:18:58 [publish_up] => 2015-06-26 04:11:05 [publish_down] => 0000-00-00 00:00:00 [images] => [urls] => [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [version] => 5 [parentid] => 0 [ordering] => 84 [metakey] => [metadesc] => [access] => 1 [hits] => 1908 [metadata] => JRegistry Object ( [data:protected] => stdClass Object ( [robots] => [author] => [rights] => [xreference] => ) ) [featured] => 0 [language] => * [xreference] => [category_title] => News & Events [category_alias] => news-a-events [category_access] => 1 [author] => Hepatitis Admin [contactid] => [parent_title] => General [parent_id] => 15 [parent_route] => general [parent_alias] => general [rating] => [rating_count] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [menu_text] => 1 [show_page_heading] => 0 [secure] => 0 [page_title] => Latest News [page_description] => Hepatitis Queensland [page_rights] => [robots] => [access-view] => 1 ) ) [slug] => 314:hepatitis-c-inquiry-report-welcomed-but-urgent-action-now-needed [catslug] => 3:news-a-events [parent_slug] => 15:general [readmore_link] => /news-media-a-events/our-news/3-news-a-events/314-hepatitis-c-inquiry-report-welcomed-but-urgent-action-now-needed [text] =>

Hepatitis Australia Media Release

For Immediate Use

26 June 2015


The report by the House of Representatives Standing Committee on Health, The Silent Disease - Inquiry into Hepatitis C in Australia has been welcomed by the peak body representing the interests of more than 230,000 Australians living with hepatitis C.

The Acting CEO of Hepatitis Australia Kevin Marriott thanked the House of Representatives Committee for their comprehensive report, which included input from more than one hundred submissions and five public hearings.

"The Inquiry has been a landmark moment for Australians living with hepatitis C. It allowed many people to make their voice heard and we thank the Committee for listening and acknowledging the diverse experiences of people impacted by hepatitis C," he said.

"The report includes a number of important recommendations, including improved data collection and monitoring of progress against the targets in the National Hepatitis C Strategy - which we strongly welcome."

"The introduction of robust targets to increase testing and supporting the use in Australia of new rapid testing technology is also a step in the right direction."

However, Hepatitis Australia believes the report falls short in two important areas - affordable access to new generation anti-viral medicines and the prevention of blood borne viruses in correctional settings.

"We are disappointed that the report is silent on recommendations around new treatment options for hepatitis C, which have been deemed cost-effective and are now awaiting a PBS listing date. These therapies offer the opportunity to transform lives and make hepatitis C a rare condition in our lifetime," Mr Marriott said.

"Hepatitis Australia remains steadfast in its position that there can be no further delay in access to interferon-free medicines for all people living with chronic hepatitis C."

Mr Marriott also welcomed the Committee's recommendation that a national strategy be developed to urgently address blood borne viruses in prisons and pointed to evidence that needle and syringe programs significantly reduce rates of hepatitis C transmission.

"Ensuring safe and hygienic tattooing and barbering practises in prisons is essential, as well as trialling a needle and syringe exchange program in at least one Australian prison, with the view to rolling out the strongest possible program nationally," he said.

"We look forward to the Government acting on the recommendations from the Committee and going one step further - making new hepatitis C medicines affordable as soon as possible, and working to remove barriers to the introduction of needle and syringe programs in prisons."

Media Contact: Fiona Beveridge 0405 902 826

If you are living with hepatitis C, please call the National Infoline on 1300 437 222

Click here for a PDF version of this media release.

Older news:

[event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) ) ) [__state_set:protected] => 1 [_db:protected] => JDatabaseMySQLi Object ( [name] => mysqli [nameQuote:protected] => ` [nullDate:protected] => 0000-00-00 00:00:00 [dbMinimum:protected] => 5.0.4 [_database:JDatabase:private] => hepqld_joomla [connection:protected] => mysqli Object ( [affected_rows] => 1 [client_info] => mysqlnd 5.0.11-dev - 20120503 - $Id: 76b08b24596e12d4553bd41fc93cccd5bac2fe7a $ [client_version] => 50011 [connect_errno] => 0 [connect_error] => [errno] => 0 [error] => [error_list] => Array ( ) [field_count] => 0 [host_info] => Localhost via UNIX socket [info] => Rows matched: 1 Changed: 1 Warnings: 0 [insert_id] => 0 [server_info] => 5.6.35 [server_version] => 50635 [stat] => Uptime: 981304 Threads: 1 Questions: 147501112 Slow queries: 350 Opens: 3536246 Flush tables: 1 Open tables: 2000 Queries per second avg: 150.311 [sqlstate] => 00000 [protocol_version] => 10 [thread_id] => 1591514 [warning_count] => 0 ) [count:protected] => 0 [cursor:protected] => 1 [debug:protected] => [limit:protected] => 0 [log:protected] => Array ( ) [offset:protected] => 0 [sql:protected] => UPDATE #__content SET hits = hits + 1 WHERE id = 314 [tablePrefix:protected] => j25_ [utf:protected] => 1 [errorNum:protected] => 0 [errorMsg:protected] => [hasQuoted:protected] => [quoted:protected] => Array ( ) ) [name:protected] => article [option:protected] => com_content [state:protected] => JObject Object ( [_errors:protected] => Array ( ) [task] => [parameters.menu] => JRegistry Object ( [data:protected] => stdClass Object ( [show_title] => [link_titles] => [show_intro] => [show_category] => [link_category] => [show_parent_category] => [link_parent_category] => [show_author] => [link_author] => [show_create_date] => [show_modify_date] => [show_publish_date] => [show_item_navigation] => [show_vote] => [show_icons] => [show_print_icon] => [show_email_icon] => [show_hits] => [show_noauth] => [urls_position] => [menu-anchor_title] => [menu-anchor_css] => [menu_image] => [menu_text] => 1 [page_title] => [show_page_heading] => 0 [page_heading] => [pageclass_sfx] => [menu-meta_description] => [menu-meta_keywords] => [robots] => [secure] => 0 ) ) [article.id] => 314 [list.offset] => 0 [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [menu_text] => 1 [show_page_heading] => 0 [secure] => 0 [page_title] => Latest News [page_description] => Hepatitis Queensland [page_rights] => [robots] => [page_heading] => Latest News ) ) [filter.published] => 1 [filter.archived] => 2 [filter.language] => ) [event_clean_cache:protected] => onContentCleanCache [_errors:protected] => Array ( ) ) ) [_basePath:protected] => /home/hepqld/public_html/components/com_content [_defaultModel:protected] => article [_layout:protected] => default [_layoutExt:protected] => php [_layoutTemplate:protected] => _ [_path:protected] => Array ( [template] => Array ( [0] => /home/hepqld/public_html/templates/if_960_j25/html/com_content/article/ [1] => /home/hepqld/public_html/components/com_content/views/article/tmpl/ ) [helper] => Array ( [0] => /home/hepqld/public_html/components/com_content/helpers/ ) ) [_template:protected] => /home/hepqld/public_html/templates/if_960_j25/html/com_content/article/default.php [_output:protected] => [_escape:protected] => htmlspecialchars [_charset:protected] => UTF-8 [_errors:protected] => Array ( ) [baseurl] => [document] => JDocumentHTML Object ( [_links] => Array ( ) [_custom] => Array ( ) [template] => [baseurl] => [params] => [_file] => [_template:protected] => [_template_tags:protected] => Array ( ) [_caching:protected] => [title] => Hepatitis C Inquiry Report welcomed; but urgent action now needed [description] => Hepatitis Queensland [link] => [base] => http://www.hepqld.asn.au/news-media-a-events/our-news/3-news-a-events/314-hepatitis-c-inquiry-report-welcomed-but-urgent-action-now-needed [language] => en-gb [direction] => ltr [_generator] => Joomla! - Open Source Content Management [_mdate] => [_tab] => [_lineEnd] => [_charset] => utf-8 [_mime] => text/html [_namespace] => [_profile] => [_scripts] => Array ( [/media/system/js/mootools-core.js] => Array ( [mime] => text/javascript [defer] => [async] => ) [/media/system/js/core.js] => Array ( [mime] => text/javascript [defer] => [async] => ) [/media/system/js/caption.js] => Array ( [mime] => text/javascript [defer] => [async] => ) ) [_script] => Array ( [text/javascript] => window.addEvent('load', function() { new JCaption('img.caption'); }); ) [_styleSheets] => Array ( ) [_style] => Array ( ) [_metaTags] => Array ( [http-equiv] => Array ( [content-type] => text/html ) [standard] => Array ( [keywords] => Hepatitis Queensland [rights] => [author] => Hepatitis Admin ) ) [_engine] => [_type] => html [_errors:protected] => Array ( ) ) [pageclass_sfx] => )

Hepatitis C Inquiry Report welcomed; but urgent action now needed

Hepatitis Australia Media Release

For Immediate Use

26 June 2015


The report by the House of Representatives Standing Committee on Health, The Silent Disease - Inquiry into Hepatitis C in Australia has been welcomed by the peak body representing the interests of more than 230,000 Australians living with hepatitis C.

The Acting CEO of Hepatitis Australia Kevin Marriott thanked the House of Representatives Committee for their comprehensive report, which included input from more than one hundred submissions and five public hearings.

"The Inquiry has been a landmark moment for Australians living with hepatitis C. It allowed many people to make their voice heard and we thank the Committee for listening and acknowledging the diverse experiences of people impacted by hepatitis C," he said.

"The report includes a number of important recommendations, including improved data collection and monitoring of progress against the targets in the National Hepatitis C Strategy - which we strongly welcome."

"The introduction of robust targets to increase testing and supporting the use in Australia of new rapid testing technology is also a step in the right direction."

However, Hepatitis Australia believes the report falls short in two important areas - affordable access to new generation anti-viral medicines and the prevention of blood borne viruses in correctional settings.

"We are disappointed that the report is silent on recommendations around new treatment options for hepatitis C, which have been deemed cost-effective and are now awaiting a PBS listing date. These therapies offer the opportunity to transform lives and make hepatitis C a rare condition in our lifetime," Mr Marriott said.

"Hepatitis Australia remains steadfast in its position that there can be no further delay in access to interferon-free medicines for all people living with chronic hepatitis C."

Mr Marriott also welcomed the Committee's recommendation that a national strategy be developed to urgently address blood borne viruses in prisons and pointed to evidence that needle and syringe programs significantly reduce rates of hepatitis C transmission.

"Ensuring safe and hygienic tattooing and barbering practises in prisons is essential, as well as trialling a needle and syringe exchange program in at least one Australian prison, with the view to rolling out the strongest possible program nationally," he said.

"We look forward to the Government acting on the recommendations from the Committee and going one step further - making new hepatitis C medicines affordable as soon as possible, and working to remove barriers to the introduction of needle and syringe programs in prisons."

Media Contact: Fiona Beveridge 0405 902 826

If you are living with hepatitis C, please call the National Infoline on 1300 437 222

Click here for a PDF version of this media release.

Older news:

© copyright 2013 | All Rights Reserved | Website design Brisbane by iFactory